Skip to main content

Nektar Therapeutics (NASDAQ: NKTR) Investor Securities Class Action Lawsuit 10/30/2018

  • If you purchased shares of Nektar Therapeutics (NASDAQ: NKTR), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

May 19, 2022 - The court of appeals affirmed the courts dismissal order. January 29, 2021 - A notice appealing the courts dismissal order was filed. December 30, 2020 - The court granted the defendants' motion to dismiss. The plaintiffs were not given leave to amend the complaint. September 17, 2020 - A motion to dismiss the second consolidated complaint was filed. August 10, 2020 - A...



You must register (for free) or login to view the entire case.